[NEW YORK] The S&P 500 and Dow Jones indexes opened lower on Tuesday as coronavirus-related worries and simmering US-China tensions weighed on sentiment at the end of what is expected to be the S&P 500's best quarter since 1998. Read more at The Business Times.
[NEW YORK] The S&P 500 and Dow Jones indexes opened lower on Tuesday as coronavirus-related worries and simmering US-China tensions weighed on sentiment at the end of what is expected to be the S&P 500's best quarter since 1998.
The Dow Jones Industrial Average fell 83.37 points, or 0.33 per cent, at the open to 25,512.43, and the S&P 500 opened lower by 3.04 points, or 0.10 per cent, at 3,050.20. The Nasdaq Composite gained 1.13 points, or 0.01 per cent, to 9,875.29 at the opening bell.For daily updates on weekdays and specially selected content for the weekend. Subscribe to
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Dow ends up 2.3% as US stocks bounce from Friday routNEW YORK: Wall Street stocks finished solidly higher on Monday (Jun 29), recovering some of last week's losses amid improved investor sentiment as ...
Read more »
GZERO VIDEO: US-China deal 'fairly solid'... for nowNEW YORK (GZERO MEDIA) - A United States-China trade deal is 'fairly solid' for now at least, says American foreign policy expert Ian Bremmer in the latest episode of World In (More Than) 60 Seconds, a video series by his company GZERO Media in which he shares his view on the week's top current issues.. Read more at straitstimes.com.
Read more »
China says will put visa restrictions on US individuals over Hong KongBEIJING (REUTERS) - China's foreign ministry said on Monday (June 29) it will impose visa restrictions on US individuals with egregious conduct related to Hong Kong, after Washington announced visa restrictions on some Chinese officials over the city.. Read more at straitstimes.com.
Read more »
Asia stocks up as China PMI, US data cheer markets worried over coronavirus surgeAsian markets were poised to follow Wall Street's firm lead on Tuesday as the sentiment boost from upbeat U.S. data outweighed the threat of ...
Read more »
Gilead prices COVID-19 drug candidate remdesivir at US$390/vial in USGilead Sciences Inc said on Monday it has priced its COVID-19 treatment candidate remdesivir at US$390 per vial in the United States and other ...
Read more »
Gilead prices COVID-19 drug candidate remdesivir at US$390 per vial in US hospitalsGilead Sciences Inc said on Monday it has priced its COVID-19 treatment candidate remdesivir at US$390 per vial in the United States and other ...
Read more »